+21.1%
PSA vs BBIO
+154.4%
-133.4%
-25.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | BBIO | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.6% | -0.1% | +0.7% | +0.7% |
| 7D | -1.8% | -3.2% | +1.4% | -1.5% |
| 30D | -8.4% | -13.6% | +5.2% | -7.1% |
| 3M | -7.8% | +7.2% | -15.1% | -8.8% |
| 6M | +0.8% | +1.5% | -0.7% | +0.2% |
| YTD | +16.5% | -5.3% | +21.8% | +16.2% |
| 1Y | +4.7% | +37.7% | -33.0% | +0.2% |
| 3Y | +21.1% | +153.9% | -132.9% | +2.7% |
| All | +21.1% | +154.4% | -133.4% | +2.7% |
Cumulative growth
Daily Returns
Daily percentage return beside BBIO.
Daily Out/Under-Performance
Portfolio return minus BBIO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded BBIO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling